Related references
Note: Only part of the references are listed.Effects of Extracellular Phosphate on Gene Expression in Murine Osteoblasts
C. Rendenbach et al.
CALCIFIED TISSUE INTERNATIONAL (2014)
Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice
Erica L. Clinkenbeard et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia
Thomas O. Carpenter et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Hereditary Deletion of the Entire FAM20C Gene in a Patient With Raine Syndrome
Farouq K. Ababneh et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy
Chad D. Touchberry et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Dosage Effect of a Phex Mutation in a Murine Model of X-Linked Hypophosphatemia
Shoji Ichikawa et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
Calcium Regulates FGF-23 Expression in Bone
Valentin David et al.
ENDOCRINOLOGY (2013)
Hexa-D-Arginine Treatment Increases 7B2•PC2 Activity in hyp-Mouse Osteoblasts and Rescues the HYP Phenotype
Baozhi Yuan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Nuclear Fibroblast Growth Factor 2 (FGF2) Isoforms Inhibit Bone Marrow Stromal Cell Mineralization Through FGF23/FGFR/MAPK In Vitro
Liping Xiao et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification
Silje Hjorth Rafaelsen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia
Nilana M. T. Barros et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
Myles Wolf et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Plasma FGF23 levels increase rapidly after acute kidney injury
Marta Christov et al.
KIDNEY INTERNATIONAL (2013)
Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study
Merche Prats et al.
BMC NEPHROLOGY (2013)
Parathyroid-Specific Deletion of Klotho Unravels a Novel Calcineurin-Dependent FGF23 Signaling Pathway That Regulates PTH Secretion
Hannes Olauson et al.
PLOS GENETICS (2013)
Mechanism of FGF23 processing in fibrous dysplasia
Nisan Bhattacharyya et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells
Shoji Ichikawa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Circulating αKlotho influences phosphate handling by controlling FGF23 production
Rosamund C. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Targeted Deletion of Klotho in Kidney Distal Tubule Disrupts Mineral Metabolism
Hannes Olauson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Altered Bone Development and an Increase in FGF-23 Expression in Enpp1-/- Mice
Neil Charles Wallace Mackenzie et al.
PLOS ONE (2012)
Protective Roles of DMP1 in High Phosphate Homeostasis
Afsaneh Rangiani et al.
PLOS ONE (2012)
The Raine Syndrome Protein FAM20C Is a Golgi Kinase That Phosphorylates Bio-Mineralization Proteins
Hiroyuki O. Ishikawa et al.
PLOS ONE (2012)
Secreted Kinase Phosphorylates Extracellular Proteins That Regulate Biomineralization
Vincent S. Tagliabracci et al.
SCIENCE (2012)
Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice
Xiaofang Wang et al.
PLOS GENETICS (2012)
Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype
Hua Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
Yumie Rhee et al.
BONE (2011)
Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) Protein Regulates Osteoblast Differentiation
Hwa Kyung Nam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The Biological Function of DMP-1 in Osteocyte Maturation Is Mediated by Its 57-kDa C-terminal Fragment
Yongbo Lu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
Emily G. Farrow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Autosomal-Recessive Hypophosphatemic Rickets Is Associated with an Inactivation Mutation in the ENPP1 Gene
Varda Levy-Litan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Loss-of-Function ENPP1 Mutations Cause Both Generalized Arterial Calcification of Infancy and Autosomal-Recessive Hypophosphatemic Rickets
Bettina Lorenz-Depiereux et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active
Takashi Shimada et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Treatment of X-Linked Hypophosphatemia with Calcitriol and Phosphate Increases Circulating Fibroblast Growth Factor 23 Concentrations
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
Regina Goetz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
Majd A. I. Mirza et al.
ATHEROSCLEROSIS (2009)
Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic rickets
Emily G. Farrow et al.
BONE (2009)
Ablation of the Galnt3 Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite Increased Fgf23 Expression
Shoji Ichikawa et al.
ENDOCRINOLOGY (2009)
Klotho is a substrate for α-, β- and γ-secretase
Laura Bloch et al.
FEBS LETTERS (2009)
Defective O-Glycosylation due to a Novel Homozygous S129P Mutation Is Associated with Lack of Fibroblast Growth Factor 23 Secretion and Tumoral Calcinosis
Clemens Bergwitz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study
Belinda J. Schouten et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Initial FGF23-Mediated Signaling Occurs in the Distal Convoluted Tubule
Emily G. Farrow et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A translocation causing increased α-Klotho level results in hypophosphatemic rickets and hyperparathyroidism
Catherine A. Brownstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Fibroblast growth factor-23 regulates parathyroid hormone and 1α-hydroxylase expression in cultured bovine parathyroid cells
Tijana Krajisnik et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The mild to moderate kidney disease (MMKD) study
Danilo Fliser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Shoji Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays
Brian H. Durham et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2007)
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Carole Peyssonnaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa et al.
NATURE (2006)
DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis
Bettina Lorenz-Depiereux et al.
NATURE GENETICS (2006)
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism
Jian Q. Feng et al.
NATURE GENETICS (2006)
The role of mutant UDP-N-acetyl-α-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis
Holly J. Garringer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men
Diana M. Antoniucci et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women
Sherri-Ann M. Burnett et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis - Secretion of fibroblast growth factor 23 requires O-glycosylation
Kentaro Kato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Pathogenic role of Fgf23 in Hyp mice
Shiguang Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D
Shiguang Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Regulation of fibroblast growth factor-23 signaling by Klotho
H Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Extended mutational analyses of FGFR1 in osteoglophonic dysplasia
EG Farrow et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone
D Bacic et al.
KIDNEY INTERNATIONAL (2006)
Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice
F Perwad et al.
ENDOCRINOLOGY (2005)
A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis
T Larsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation
KE White et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia
A Benet-Pagès et al.
HUMAN MOLECULAR GENETICS (2005)
FGF23 is processed by proprotein convertases but not by PHEX
A Beret-Pagès et al.
BONE (2004)
Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis
O Topaz et al.
NATURE GENETICS (2004)
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
KB Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
Y Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
KE White et al.
KIDNEY INTERNATIONAL (2001)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
KE White et al.
NATURE GENETICS (2000)
Share Paper
